 Connection
Richard Duke to Fas Ligand Protein
This is a "connection" page, showing publications Richard Duke has written about Fas Ligand Protein.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.778 |
|
|
|
-
Modiano JF, Bellgrau D, Cutter GR, Lana SE, Ehrhart NP, Ehrhart E, Wilke VL, Charles JB, Munson S, Scott MC, Pozniak J, Carlson CS, Schaack J, Duke RC. Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer. Mol Ther. 2012 Dec; 20(12):2234-43.
Score: 0.434
-
Duke RC. Methods of analyzing chromatin changes accompanying apoptosis of target cells in killer cell assays. Methods Mol Biol. 2004; 282:43-66.
Score: 0.060
-
Duke RC, Newell E, Schleicher M, Meech S, Bellgrau D. Transplantation of cells and tissues expressing Fas ligand. Transplant Proc. 1999 May; 31(3):1479-81.
Score: 0.043
-
Hedlund TE, Meech SJ, Srikanth S, Kraft AS, Miller GJ, Schaack JB, Duke RC. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells. Cell Death Differ. 1999 Feb; 6(2):175-82.
Score: 0.043
-
Bellgrau D, Duke RC. Apoptosis and CD95 ligand in immune privileged sites. Int Rev Immunol. 1999; 18(5-6):547-62.
Score: 0.042
-
Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature. 1995 Oct 19; 377(6550):630-2.
Score: 0.034
-
Modiano JF, Sun J, Lang J, Vacano G, Patterson D, Chan D, Franzusoff A, Gianani R, Meech SJ, Duke R, Bellgrau D. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells. Clin Immunol. 2004 Jul; 112(1):54-65.
Score: 0.015
-
Bianco SR, Sun J, Fosmire SP, Hance K, Padilla ML, Ritt MG, Getzy DM, Duke RC, Withrow SJ, Lana S, Matthiesen DT, Dow SW, Bellgrau D, Cutter GR, Helfand SC, Modiano JF. Enhancing antimelanoma immune responses through apoptosis. Cancer Gene Ther. 2003 Sep; 10(9):726-36.
Score: 0.015
-
Zuraff-Perryman LA, Duke RC, Setser E, Nelson DP, Bellgrau D. Murine heart transgenic Fas ligand expression protects against allograft rejection. Transplant Proc. 2002 Dec; 34(8):3396-8.
Score: 0.014
-
Urquhart JL, Meech SJ, Marr DG, Shellman YG, Duke RC, Norris DA. Regulation of Fas-mediated apoptosis by N-ras in melanoma. J Invest Dermatol. 2002 Sep; 119(3):556-61.
Score: 0.014
-
Nelson DP, Setser E, Hall DG, Schwartz SM, Hewitt T, Klevitsky R, Osinska H, Bellgrau D, Duke RC, Robbins J. Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest. 2000 May; 105(9):1199-208.
Score: 0.012
-
Srikanth S, Franklin CC, Duke RC, Kraft RS. Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis. Mol Cell Biochem. 1999 Sep; 199(1-2):169-78.
Score: 0.011
-
Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, Duke RC, Scheinman RI. NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 1999 Jun; 6(6):570-82.
Score: 0.011
-
Desbarats J, Duke RC, Newell MK. Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells. Nat Med. 1998 Dec; 4(12):1377-82.
Score: 0.011
-
Leon RP, Hedlund T, Meech SJ, Li S, Schaack J, Hunger SP, Duke RC, DeGregori J. Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A. 1998 Oct 27; 95(22):13159-64.
Score: 0.010
-
Hedlund TE, Duke RC, Schleicher MS, Miller GJ. Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate. 1998 Jul 01; 36(2):92-101.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|